Sontag Advisory »

Silverback Therapeutics shares owned by Sontag Advisory

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Sontag Advisory from 13F filings

Historical chart of Sontag Advisory investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Sontag Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Sontag Advisory

Quarter filed Position value Share count Share price at filing
2025-12-31 $276k 24k 11.65

More positions owned by Sontag Advisory

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Index Fds Growth Etf (VUG)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Core Univrsl Usd (IUSB)
Vanguard Malvern Fds Strm Infproidx (VTIP)

View all positions for Sontag Advisory

Top funds holding Silverback Therapeutics

RA Capital Management
OrbiMed Advisors
Deerfield Management Company
Rubric Capital Management
BlackRock
Sr One Capital Management
Standard Life Aberdeen
Vanguard Group
State Street Corporation
Alliancebernstein
Franklin Resources
UBS Group
Tyro Capital Management
Citadel Advisors
Casdin Capital

View all funds holding Silverback Therapeutics